Literature DB >> 5475848

Reversible encephalopathy and acute renal failure after cephaloridine.

R Gabriel, R D Foord, A M Joekes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5475848      PMCID： PMC1819787          DOI： 10.1136/bmj.4.5730.283

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  LABORATORY AND CLINICAL RESULTS WITH CEPHALORIDINE.

Authors:  G T STEWART; R J HOLT
Journal:  Lancet       Date:  1964-12-19       Impact factor: 79.321

2.  Subacute toxicity of cephaloridine to various species.

Authors:  R M Atkinson; J D Caisey; J P Currie; T R Middleton; D A Pratt; H M Sharpe; E G Tomich
Journal:  Toxicol Appl Pharmacol       Date:  1966-05       Impact factor: 4.219

3.  The localisation of cephaloridine and nitrofurantoin in the kidney.

Authors:  G A Currie; P J Little; S J McDonald
Journal:  Nephron       Date:  1966       Impact factor: 2.847

4.  Cephaloridine serum levels in patients on maintenance haemodialysis.

Authors:  J R Curtis; M J Marshall
Journal:  Br Med J       Date:  1970-04-18

5.  CLINICAL TRIAL OF CEPHALORIDINE (CEPORIN), A NEW BROAD-SPECTRUM ANTIBIOTIC DERIVED FROM CEPHALOSPORIN C.

Authors:  J M MURDOCH; C F SPEIRS; A M GEDDES; E T WALLACE
Journal:  Br Med J       Date:  1964-11-14
  5 in total
  6 in total

1.  Drug-induced renal diseases.

Authors:  A P Mukherjee
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

2.  Severe chronic intra-abdominal sepsis: a report of 3 cases and a review of patient management.

Authors:  C H Browne; E Gross; G C Hanson; A K Webb
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

3.  Nephrotoxicity of cephaloridine.

Authors:  T Rosenthal; H Boichis
Journal:  Br Med J       Date:  1971-10-09

Review 4.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Quantitative structure activity relationship for inhibition of human organic cation/carnitine transporter.

Authors:  Lei Diao; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2010-09-29       Impact factor: 4.939

6.  Assessment of the nephrotoxic potential of ceftazidime and a ceftazidime/tobramycin combination in volunteers.

Authors:  A W Mondorf; F T Heynold; J E Scherberich; H Hess; W Schoeppe
Journal:  Infection       Date:  1983       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.